Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
24.97
-0.40 (-1.58%)
At close: Jul 23, 2026, 4:00 PM EDT
24.97
0.00 (0.00%)
After-hours: Jul 23, 2026, 4:21 PM EDT
Privia Health Group Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Privia Health Group stock has a consensus rating of "Strong Buy" and an average price target of $31.74. The average 1-year stock price forecast is 27.11% higher than the current stock price, while the lowest is $24 (-3.88%) and the highest is $40 (+60.19%).
Price Target: $31.74 (+27.11%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Privia Health Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 14 | 14 | 14 | 13 | 13 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 21 | 21 | 21 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $31 | Buy | Maintains | $31 | +24.15% | Jul 9, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $33 | Buy | Maintains | $33 | +32.16% | Jun 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $34 | Buy | Maintains | $34 | +36.16% | May 28, 2026 |
| Barclays | Barclays | Hold Maintains $25 → $24 | Hold | Maintains | $25 → $24 | -3.88% | May 26, 2026 |
| Citi | Citi | Buy Maintains $32 | Buy | Maintains | $32 | +28.15% | May 14, 2026 |
Financial Forecast
Revenue This Year
2.42B
from 2.12B
Increased by 14.20%
Revenue Next Year
2.67B
from 2.42B
Increased by 9.95%
EPS This Year
0.95
from 0.99
Decreased by -3.91%
EPS Next Year
1.10
from 0.95
Increased by 15.45%
EPS and Forward PE are based on non-GAAP adjusted numbers.